Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Spinal dysraphisms are defined as a congenital malformation characterized by a defect in the closure of the neural tube in the caudal region. They are divided into two groups: open dysraphisms, where the skin covering is absent; and closed dysraphisms, where the skin abnormality is less obvious and diagnosis is sometimes more difficult. Both open and closed dysraphisms can cause a variety of neurological disorders, including urinary and fecal dysfunction, which is often more severe in open dysraphisms than in closed dysraphisms, which sometimes go unnoticed and may only become symptomatic during growth. As a result, urinary and fecal repercussions in closed dysraphisms are sometimes overlooked, and the literature on this subject remains scarce. The hypothesis is that a better understanding of the urinary and fecal repercussions of closed dysraphisms would allow for more appropriate and standardized follow-up of these children. The main objective of the study is to describe the urinary impact on children with spinal dysraphism, as well as how they are managed.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Dyspraphism |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| description of the impact | Other | Study of urinary and fecal impact of closed and dysraphism in the pediatric population |
|
| Measure | Description | Time Frame |
|---|---|---|
| Rate of bladder dysfunction | rate of bladder dysfunction in children with open or closed dysraphism | up to 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Urinary symptoms | urinary symptoms described by patients | up to 5 years |
| Fecal symptoms | fecal symptoms that may be described by patients |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients will be selected based on their MRI reports specifying a diagnosis of dysraphism or via diagnostic codes and surgical procedures specific to dysraphism.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Louise RENOULT | Contact | +33241353637 | louise.renoult@chu-angers.fr | |
| Louise RENOULT | Contact | louise.renoult@chu-angers.fr |
| Name | Affiliation | Role |
|---|---|---|
| Louise RENOULT | University Hospital, Angers | Study Chair |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| up to 5 years |
| Urinary treatments implemented | urinary treatments that may be implemented during follow-up | up to 5 years |
| Fecal treatments implemented | fecal treatments that may be implemented during follow-up | up to 5 years |
| Prenatal diagnosis | presence or absence of a prenatal diagnosis | Baseline |
| Clinical signs | linical signs that led to the diagnosis of dysraphism | Baseline |
| general symptoms | general symptoms that led to the diagnosis of dysraphism | Baseline |